Global SPECT Scanners Market Size By Type (Single Purpose SPECT Scanner, Multi-Purpose SPECT Scanner), By Application (Oncology, Cardiology), By Region, And Segment Forecasts, 2023 to 2032

The Global SPECT (Single Photon Emission Computed Tomography) Scanners Market was valued at USD 2.3 billion in 2023 and is anticipated to reach USD 4.1 billion by 2031, growing at a CAGR of 7.3% during the forecast period from 2023 to 2031. This growth is driven by the increasing prevalence of chronic diseases such as cancer and cardiovascular disorders, expanding geriatric population, and rising demand for functional imaging tools for early disease diagnosis. Technological advancements, including hybrid imaging systems and the integration of AI in imaging diagnostics, are further fueling market expansion.

Drivers:

1. Increasing Prevalence of Chronic and Neurological Diseases:

With the global burden of conditions like cancer, Alzheimer's, and cardiovascular diseases on the rise, there is an increased demand for SPECT scanners to enable early diagnosis and monitor therapeutic efficacy.

2. Advancements in Hybrid Imaging Technologies:

The integration of SPECT with CT (SPECT/CT) offers enhanced anatomical and functional imaging capabilities, gaining popularity in oncology, cardiology, and neurology applications.

3. Growth in Geriatric Population:

Older adults are more prone to chronic diseases requiring diagnostic imaging. The aging global population significantly contributes to the increased need for SPECT imaging.

Restraints:

1. High Equipment and Installation Costs:

SPECT scanners involve considerable capital investment, installation expenses, and ongoing maintenance costs, limiting their adoption in low-resource healthcare settings.

2. Limited Spatial Resolution Compared to Other Modalities:

Despite advancements, SPECT scanners still offer lower resolution than PET or MRI, which can restrict their use in certain diagnostic applications.

Opportunity:

1. Expanding Application in Oncology and Neurology:

There is a growing opportunity for SPECT scanners in precision oncology and brain imaging, especially with the advent of targeted radiopharmaceuticals.

2. Penetration in Emerging Markets:

Countries in Asia-Pacific, Latin America, and Africa are rapidly expanding healthcare infrastructure and investing in advanced diagnostic technologies, presenting untapped growth potential.

Market by System Type Insights:

In 2023, the Hybrid SPECT/CT segment accounted for the largest market share, driven by its combined functional and anatomical imaging capabilities. Hybrid systems are increasingly adopted in clinical practice for accurate localization of lesions and improved patient management. Standalone SPECT systems remain relevant in smaller diagnostic centers due to lower cost but are expected to be gradually replaced by hybrid models in high-volume centers.

Market by End-use Insights:

Hospitals emerged as the dominant end-use segment in 2023, holding more than 50% of the market share. Their large patient throughput, comprehensive diagnostic facilities, and access to advanced technologies contribute to this dominance. Diagnostic imaging centers are also witnessing steady growth due to outsourcing of imaging services and a rise in ambulatory care demand.

Market by Regional Insights:

North America led the global market in 2023, supported by advanced healthcare infrastructure, high per capita healthcare expenditure, and the presence of key market players. Asia-Pacific is projected to grow at the fastest pace during the forecast period due to increasing healthcare investments, awareness of early disease detection, and government initiatives in countries such as China and India.

Competitive Scenario:

Key players in the Global SPECT Scanners Market include GE HealthCare, Siemens Healthineers, Canon Medical Systems Corporation, Digirad Corporation, Mediso Ltd., MILabs B.V., Spectrum Dynamics Medical, and Bruker Corporation. These companies are focusing on product innovation, strategic partnerships, and geographic expansion.

Key Market Developments:

2023: GE HealthCare introduced a next-generation SPECT/CT system with deep learning algorithms for accelerated and high-precision imaging.

2024: Siemens Healthineers entered a partnership with a major European oncology network to deploy SPECT scanners integrated with AI for personalized diagnostics.

2025: Mediso Ltd. announced FDA clearance for its new portable SPECT system tailored for neurology-focused imaging in outpatient settings.

Scope of Work – Global SPECT Scanners Market

Report Metric Details

Market Size (2023) USD 2.3 billion

Projected Market Size (2031) USD 4.1 billion

CAGR (2023-2031) 7.3%

Market Segments By System Type (Standalone SPECT, Hybrid SPECT/CT), By End-use (Hospitals, Diagnostic Imaging Centers, Others), By Region

Growth Drivers Rise in chronic diseases, hybrid imaging advancements, aging population

Opportunities Expansion in emerging markets, oncology and neurology imaging trends

FAQs:

1) What is the current market size of the Global SPECT Scanners Market?

The market size in 2023 is USD 2.3 billion.

2) What is the major growth driver of the Global SPECT Scanners Market?

The major driver is the increasing prevalence of chronic diseases and advancements in hybrid SPECT/CT systems.

3) Which is the largest region during the forecast period in the Global SPECT Scanners Market?

North America holds the largest market share due to its robust healthcare infrastructure.

4) Which segment accounted for the largest market share in Global SPECT Scanners Market?

The Hybrid SPECT/CT segment accounted for the largest share by system type.

5) Who are the key market players in the Global SPECT Scanners Market?

Key players include GE HealthCare, Siemens Healthineers, Canon Medical Systems, Digirad Corporation, and Mediso Ltd.

Would you like the report output in a Word document as well?